Department of Nutrition, Harvard School of Public Health, 655 Huntington Avenue, Boston, MA 02115, USA.
Am J Epidemiol. 2013 Mar 15;177(6):504-13. doi: 10.1093/aje/kws261. Epub 2013 Feb 13.
Few studies have investigated the relationship between overall diet and the risk of prostate cancer. We examined the association between 3 diet quality indices-the Healthy Eating Index-2005 (HEI-2005), Alternate Healthy Eating Index-2010 (AHEI-2010), and alternate Mediterranean diet score (aMED)-and prostate cancer risk. At baseline, dietary intake was assessed in a cohort of 293,464 US men in the National Institutes of Health (NIH)-AARP Diet and Health Study. Cox proportional hazards regression was used to estimate hazard ratios. Between 1995 and 2006, we ascertained 23,453 incident cases of prostate cancer, including 2,251 advanced cases and 428 fatal cases. Among men who reported a history of prostate-specific antigen testing, high HEI-2005 and AHEI-2010 scores were associated with lower risk of total prostate cancer (for the highest quintile compared with the lowest, hazard ratio (HR) = 0.92, 95% confidence interval (CI): 0.86, 0.98, P for trend = 0.01; and HR = 0.93, 95% CI: 0.88, 0.99, P for trend = 0.05, respectively). No significant association was observed between aMED score and total prostate cancer or between any of the indices and advanced or fatal prostate cancer, regardless of prostate-specific antigen testing status. In individual component analyses, the fish component of aMED and ω-3 fatty acids component of AHEI-2010 were inversely associated with fatal prostate cancer (HR = 0.79, 95% CI: 0.65, 0.96, and HR = 0.94, 95% CI: 0.90, 0.98, respectively).
很少有研究调查整体饮食与前列腺癌风险之间的关系。我们研究了三种饮食质量指数——健康饮食指数-2005(HEI-2005)、替代健康饮食指数-2010(AHEI-2010)和替代地中海饮食评分(aMED)——与前列腺癌风险之间的关系。在研究的基线阶段,美国国立卫生研究院(NIH)-AARP 饮食与健康研究的 293464 名美国男性评估了饮食摄入情况。使用 Cox 比例风险回归来估计风险比。在 1995 年至 2006 年期间,我们确定了 23453 例前列腺癌新发病例,包括 2251 例晚期病例和 428 例死亡病例。在报告过前列腺特异性抗原检测史的男性中,高 HEI-2005 和 AHEI-2010 评分与总前列腺癌风险较低相关(与最低五分位数相比,最高五分位数的风险比(HR)为 0.92,95%置信区间(CI):0.86,0.98,P 趋势=0.01;HR=0.93,95%CI:0.88,0.99,P 趋势=0.05)。无论是否进行了前列腺特异性抗原检测,aMED 评分与总前列腺癌之间,或任何指数与晚期或致命性前列腺癌之间均未观察到显著关联。在个体成分分析中,aMED 的鱼类成分和 AHEI-2010 的ω-3 脂肪酸成分与致命性前列腺癌呈负相关(HR=0.79,95%CI:0.65,0.96 和 HR=0.94,95%CI:0.90,0.98)。